(Juste pour dire dans quelle main est Madagascar qui vient de lancer une campagne de vaccination de toute la population avec Bavarian Nordic contre le monkeypox. Et cela me paraît bizarre que le monkeypox arrive juste après le coup d'état militaire qui a bouté hors du pays un président qui n'était pas favorable à la big pharma américaine et qui avait développé un médicament à base d'artimissinine (artémisia) contre le covid. En fait, la révolte populaire n'a été qu'une révolution de couleur de plus qui a fonctionné. A mon avis, les pays africains devraient se méfier, déjà en Tanzanie, le président non favorable à la big pharma est mort et a été remplacée par une présidente favorable à fond à la big pharma américaine. Ah, oui, je rappelle que c'est la même chose au Brésil, lula a été sorti de prison, a été candidat à l'élection et a battu bolsonaro défavorable à la big pharma américaine et à peine élu a obligé les parents à vacciner leurs enfants sous peine de perdre les allocations sociales. note de rené)

Monkeypox Vax Maker Bavarian Nordic Is Owned by Pro-Depopulation World Economic Forum-Linked Money Managers

ByAmerican Faith

July 21, 2022

WEF contributor wants the world “population that there was 500 years ago.”

QUICK FACTS:

• Monkeypox vaccine manufacturer Bavarian Nordic just closed a deal with the U.S. for an additional 2.5 million doses of its smallpox/monkeypox vaccine “Jynneos” as an undisclosed European country also ordered an additional 1.5 million doses.
• Bavarian Nordic president and CEO Paul Chaplin praised the buying governments for their “thinking beyond the current situation and building stockpiles to secure future preparedness.”
• The vaccine maker is owned by American investment management company Invesco, a company officially partnered with the Great Reset-promoting World Economic Forum (WEF), according to the WEF’s website.
• Invesco CEO Martin L. Flanagan was a participant at the WEF 2022 Annual Meeting, as well as the Forum’s 2019 and 2020 meetings.

Screenshot from invesco.com taken July 21, 2022

• A now-deleted page on the WEF website titled “Biological weapons, countering the threat” outlines how Bavarian Nordic participated as a Dec 8, 2011 WEF meeting panelist who “shared perspectives on a number of key approaches to dealing with bio-weapons threats including surveillance and detection, prophylactic vaccines, therapeutics and biorisk management, including awareness–raising of dual-use risks and the potential for international biorisk management standards to enhance the existing confidence building measures associated with the Convention.” Here is an archived version of the WEF publication.
• Primatologist and WEF “agenda contributor” Jane Goodall in Jan 2020 told the Forum she believes that the world would be better off if over 90% of the human population did not exist. “We cannot hide away from human population growth,” Goodall claimed. “All these things we talk about wouldn’t be a problem if there was the size of population that there was 500 years ago.”
• Another WEF publication says “Fewer people are good for the climate.”

WHO ELSE OWNS BAVARIAN NORDIC?:

• Jynneos monkeypox vaccine manufacturer Bavarian Nordic is also owned by The Vanguard Group and BlackRock, the world’s two largest financial asset managers.
• BlackRock is the official WEF partner that also owns COVID-19 vaccine manufacturers Pfizer, Moderna, Johnson & Johnson, AstraZeneca, and Novavax.

BACKGROUND:

• Bill Gates, whose Bill & Melinda Gates Foundation is also officially partnered with the World Economic Forum, is often criticized for a TedTalk during which he claimed that “vaccines” can be used to “lower” the world population by “10 or 15 percent.”
• “First, we’ve got population,” Gates said during the TedTalk. “The world today has 6.8 billion people. That’s headed up to about nine billion. Now, if we do a really great job on new vaccines, health care, reproductive health services, we could lower that by, perhaps, 10 or 15 percent. But there, we see an increase of about 1.3.”
• Gates says, for example, that “population growth in Africa is a challenge” to be overcome, in another WEF publication.
• It was reported Tuesday that Bavarian Nordic’s shares “ended the last trading session 7.1% higher at $11.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock’s 7.9% gain over the past four weeks.”